IBDY — iShares iBonds Dec 2033 Term Corporate ETF
Data updated: 2026-06-26
IBDY — iShares iBonds Dec 2033 Term Corporate ETF data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. Intermediate Corporate Bond · $1.07B AUM · 0.10% expense ratio · 6.3% 1-yr return. From SEC regulatory filings.
IBDY Fund Overview
IBDY — iShares iBonds Dec 2033 Term Corporate ETF is a US ETF managed by iSHARES TRUST, categorised as Intermediate Corporate Bond. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: iSHARES TRUST
- Category: Intermediate Corporate Bond
- Assets under management: $1.07B
- 1-year return: 6.3%
- Ticker: IBDY
- SEC CIK: 0001100663
- SEC series ID: S000080643
- Share class ID: C000243159
IBDY Holdings
Top 10 holdings of iShares iBonds Dec 2033 Term Corporate ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| BlackRock Funds III | 8.78% |
| Pfizer Investment Enterprises Pte. Ltd. | 1.56% |
| Amgen, Inc. | 1.37% |
| AT&T, Inc. | 0.99% |
| Amazon.com, Inc. | 0.92% |
| Oracle Corp. | 0.90% |
| Abbott Laboratories | 0.89% |
| T-Mobile USA, Inc. | 0.82% |
| Salesforce, Inc. | 0.81% |
| Alphabet, Inc. | 0.78% |
IBDY Portfolio Allocation
Asset-class allocation of iShares iBonds Dec 2033 Term Corporate ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Fixed Income | 98.3% |
| Cash & Equivalents | 9.2% |
IBDY Performance
Total returns for IBDY (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 0.1% |
| 1 year | 6.3% |
| 3 years (annualised) | 5.9% |
IBDY Risk Information
Risk metrics for IBDY, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 3.5%
IBDY Costs and Fees
IBDY costs about $10 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.10%
- Gross expense ratio: 0.10%
- Portfolio turnover: 3%
- Brokerage commissions: 0.00 bps of average net assets (SEC N-CEN)
IBDY Cashflows
Over the 12 months to 2026-04, iShares iBonds Dec 2033 Term Corporate ETF had net inflows of $337.59M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | $16.85M |
| 2026-03 | $7.90M |
| 2026-02 | $56.47M |
| 2026-01 | $37.93M |
| 2025-12 | $31.38M |
| 2025-11 | $19.68M |
IBDY Debt Constituents
Largest debt holdings of iShares iBonds Dec 2033 Term Corporate ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| Pfizer Investment Enterprises Pte. Ltd. | 1.56% |
| Amgen, Inc. | 1.37% |
| AT&T, Inc. | 0.99% |
| Amazon.com, Inc. | 0.92% |
| Oracle Corp. | 0.90% |
| Abbott Laboratories | 0.89% |
| T-Mobile USA, Inc. | 0.82% |
| Salesforce, Inc. | 0.81% |
| Alphabet, Inc. | 0.78% |
| Enbridge, Inc. | 0.74% |
IBDY Prospectus and SEC Filings
Official iShares iBonds Dec 2033 Term Corporate ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other Intermediate Corporate Bond funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.